Implications for Management of PET Amyloid Classification Technology
Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to explore the impact of an amyloid positron emission
tomography and computed tomography (PET/CT) scan on physician diagnosis and management,
including drug management and care practices, for patients with a diagnosis of cognitive
impairment. This study also intends to capture specific patient-reported outcomes related to
patient burden, confidence and satisfaction.
The hypothesis is that to aid early diagnosis, individuals with a diagnostically uncertain
etiology for their dementia will benefit from knowledge of amyloid plaque burden status,
through an alteration of patient diagnosis and management, which will lead to significant
changes in patient and care partner reported outcomes.